AI assistant
Sending…
Novartis AG — Director's Dealing 2011
Jan 21, 2011
940_dirs_2011-01-21_5b0009d1-f4c2-4828-96cb-a9ba44205fc7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Marina Biotech, Inc. (MRNA)
CIK: 0000737207
Period of Report: 2011-01-19
Reporting Person: Novartis Bioventures Ltd (10% Owner)
Reporting Person: NOVARTIS AG (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-01-19 | Common Stock | S | 10900 | $1.50 | Disposed | 2888170 | Direct |
| 2011-01-19 | Common Stock | S | 2900 | $1.51 | Disposed | 2885270 | Direct |
| 2011-01-19 | Common Stock | S | 6400 | $1.52 | Disposed | 2878870 | Direct |
| 2011-01-19 | Common Stock | S | 600 | $1.5225 | Disposed | 2878270 | Direct |
| 2011-01-19 | Common Stock | S | 500 | $1.525 | Disposed | 2877770 | Direct |
| 2011-01-19 | Common Stock | S | 3300 | $1.53 | Disposed | 2874470 | Direct |
| 2011-01-19 | Common Stock | S | 8400 | $1.54 | Disposed | 2866070 | Direct |
| 2011-01-19 | Common Stock | S | 400 | $1.55 | Disposed | 2865670 | Direct |
| 2011-01-19 | Common Stock | S | 8600 | $1.56 | Disposed | 2857070 | Direct |
| 2011-01-19 | Common Stock | S | 700 | $1.58 | Disposed | 2856370 | Direct |
| 2011-01-19 | Common Stock | S | 100 | $1.59 | Disposed | 2856270 | Direct |
| 2011-01-20 | Common Stock | S | 1000 | $1.22 | Disposed | 2855270 | Direct |
| 2011-01-20 | Common Stock | S | 800 | $1.23 | Disposed | 2854470 | Direct |
| 2011-01-20 | Common Stock | S | 1800 | $1.24 | Disposed | 2852670 | Direct |
| 2011-01-20 | Common Stock | S | 2100 | $1.25 | Disposed | 2850570 | Direct |
| 2011-01-20 | Common Stock | S | 2700 | $1.26 | Disposed | 2847870 | Direct |
| 2011-01-20 | Common Stock | S | 1000 | $1.27 | Disposed | 2846870 | Direct |
| 2011-01-20 | Common Stock | S | 200 | $1.29 | Disposed | 2846670 | Direct |
| 2011-01-20 | Common Stock | S | 2000 | $1.30 | Disposed | 2844670 | Direct |
| 2011-01-20 | Common Stock | S | 2500 | $1.31 | Disposed | 2842170 | Direct |
| 2011-01-20 | Common Stock | S | 1943 | $1.32 | Disposed | 2840227 | Direct |
| 2011-01-20 | Common Stock | S | 2057 | $1.33 | Disposed | 2838170 | Direct |
| 2011-01-20 | Common Stock | S | 2700 | $1.35 | Disposed | 2835470 | Direct |
| 2011-01-20 | Common Stock | S | 208 | $1.37 | Disposed | 2835262 | Direct |
| 2011-01-20 | Common Stock | S | 6292 | $1.38 | Disposed | 2828970 | Direct |
| 2011-01-20 | Common Stock | S | 4500 | $1.39 | Disposed | 2824470 | Direct |
| 2011-01-20 | Common Stock | S | 5200 | $1.40 | Disposed | 2819270 | Direct |
| 2011-01-20 | Common Stock | S | 1500 | $1.41 | Disposed | 2817770 | Direct |
| 2011-01-20 | Common Stock | S | 2800 | $1.42 | Disposed | 2814970 | Direct |
| 2011-01-20 | Common Stock | S | 4400 | $1.43 | Disposed | 2810570 | Direct |
Footnotes
F1: These shares are directly owned by Novartis Bioventures Ltd. Novartis Bioventures Ltd. is a wholly-owned indirect subsidiary of Novartis AG, which is an indirect beneficial owner of the reported securities.
F2: Transactions continued on a subsequent Form 4 due to limitations on the number of reportable transactions.
More from Novartis AG
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Annual Report
2026
Feb 4
Regulatory Filings
2026
Jan 16
Regulatory Filings
2026
Jan 16
Regulatory Filings
2026
Jan 16
Regulatory Filings
2026
Jan 16